InvestorsHub Logo
Followers 0
Posts 20
Boards Moderated 0
Alias Born 06/25/2020

Re: None

Wednesday, 07/15/2020 12:57:30 AM

Wednesday, July 15, 2020 12:57:30 AM

Post# of 16708
This Alzheimer researcher (DR. Tohro Hasegawa) has great knowledge in Ifenprodil.

Sample of his tweets. scroll through them on twitter:

"Algernon co's repurposed drug, Ifenprodil is exactly promise. This drug modifys NMDA receptor activity and
cures COVID-19 ALI, which indicates that our blood HCA is very danger. Because HCA is a strong agonist for NMDA receptor."

"COVID-19 has an another face to neurological disease. Loss of sense of smell and taste. unconsciousness.
COVID-19 induces NMDA receptor abnormality with cooperation with our blood HCA."

"Why did our Japanese die very fewer than European and American by COVID-19? Prof. Yamanaka pointed out factor-X. What is factor-X? Do you know Ifenprodil drug of Algernon co. for the treatment of COVID-19 ALI? This is a hint. Ifenprodil inhibits NMDA recep."

"This Ifenprodil inhibits lung cell NMDA receptor which induces COVID-19-induced cytokine storm. Our homocysteic acid (HCA) is a strong agonist of NMDA receptor.
Our Japanese HCA level might be lower than that of European and American. That is factor-X."

https://twitter.com/Hasetohru